Links to Exploration step
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Increased plasma neurotensin concentrations in patients with
Parkinson's disease</title><author><name sortKey="Schimpff, R" sort="Schimpff, R" uniqKey="Schimpff R" first="R" last="Schimpff">R. Schimpff</name></author><author><name sortKey="Avard, C" sort="Avard, C" uniqKey="Avard C" first="C" last="Avard">C. Avard</name></author><author><name sortKey="Fenelon, G" sort="Fenelon, G" uniqKey="Fenelon G" first="G" last="Fenelon">G. Fenelon</name></author><author><name sortKey="Lhiaubet, A" sort="Lhiaubet, A" uniqKey="Lhiaubet A" first="A" last="Lhiaubet">A. Lhiaubet</name></author><author><name sortKey="Tenneze, L" sort="Tenneze, L" uniqKey="Tenneze L" first="L" last="Tenneze">L. Tenneze</name></author><author><name sortKey="Vidailhet, M" sort="Vidailhet, M" uniqKey="Vidailhet M" first="M" last="Vidailhet">M. Vidailhet</name></author><author><name sortKey="Rostene, W" sort="Rostene, W" uniqKey="Rostene W" first="W" last="Rostene">W. Rostene</name></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">11385014</idno><idno type="pmc">1737416</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1737416</idno><idno type="RBID">PMC:1737416</idno><idno type="doi">10.1136/jnnp.70.6.784</idno><date when="2001">2001</date><idno type="wicri:Area/Pmc/Corpus">000331</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000331</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Increased plasma neurotensin concentrations in patients with
Parkinson's disease</title><author><name sortKey="Schimpff, R" sort="Schimpff, R" uniqKey="Schimpff R" first="R" last="Schimpff">R. Schimpff</name></author><author><name sortKey="Avard, C" sort="Avard, C" uniqKey="Avard C" first="C" last="Avard">C. Avard</name></author><author><name sortKey="Fenelon, G" sort="Fenelon, G" uniqKey="Fenelon G" first="G" last="Fenelon">G. Fenelon</name></author><author><name sortKey="Lhiaubet, A" sort="Lhiaubet, A" uniqKey="Lhiaubet A" first="A" last="Lhiaubet">A. Lhiaubet</name></author><author><name sortKey="Tenneze, L" sort="Tenneze, L" uniqKey="Tenneze L" first="L" last="Tenneze">L. Tenneze</name></author><author><name sortKey="Vidailhet, M" sort="Vidailhet, M" uniqKey="Vidailhet M" first="M" last="Vidailhet">M. Vidailhet</name></author><author><name sortKey="Rostene, W" sort="Rostene, W" uniqKey="Rostene W" first="W" last="Rostene">W. Rostene</name></author></analytic><series><title level="j">Journal of Neurology, Neurosurgery, and Psychiatry</title><idno type="ISSN">0022-3050</idno><idno type="eISSN">1468-330X</idno><imprint><date when="2001">2001</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p>Plasma neurotensin (NT) was measured by radioimmunoassay in
propanol extracted and unextracted plasma from 16 parkinsonian patients
(four before treatment) and 16 age and sex matched controls. Mean
plasma NT concentrations were consistently higher in parkinsonian patients than in controls and higher in the four untreated patients than in levodopa treated patients suggesting that plasma NT measurement may represent an easy detectable additional index in diagnosing parkinsonism and provides a novel approach to research in this field.
</p></div></front></TEI><pmc article-type="brief-report"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<front><journal-meta><journal-id journal-id-type="nlm-ta">J Neurol Neurosurg Psychiatry</journal-id><journal-title>Journal of Neurology, Neurosurgery, and Psychiatry</journal-title><issn pub-type="ppub">0022-3050</issn><issn pub-type="epub">1468-330X</issn><publisher><publisher-name>BMJ Group</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">11385014</article-id><article-id pub-id-type="pmc">1737416</article-id><article-id pub-id-type="doi">10.1136/jnnp.70.6.784</article-id><article-categories><subj-group subj-group-type="heading"><subject>Short Report</subject></subj-group></article-categories><title-group><article-title>Increased plasma neurotensin concentrations in patients with
Parkinson's disease</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Schimpff</surname><given-names>R</given-names></name></contrib><contrib contrib-type="author"><name><surname>Avard</surname><given-names>C</given-names></name></contrib><contrib contrib-type="author"><name><surname>Fenelon</surname><given-names>G</given-names></name></contrib><contrib contrib-type="author"><name><surname>Lhiaubet</surname><given-names>A</given-names></name></contrib><contrib contrib-type="author"><name><surname>Tenneze</surname><given-names>L</given-names></name></contrib><contrib contrib-type="author"><name><surname>Vidailhet</surname><given-names>M</given-names></name></contrib><contrib contrib-type="author"><name><surname>Rostene</surname><given-names>W</given-names></name></contrib></contrib-group><aff>INSERM U 339, Hôpital Saint Antoine, 184 rue du Faubourg, St Antoine, 75012 Paris, France.</aff><pub-date pub-type="ppub"><month>6</month><year>2001</year></pub-date><volume>70</volume><issue>6</issue><fpage>784</fpage><lpage>786</lpage><self-uri xlink:role="pdf" xlink:type="simple" xlink:href="http://jnnp.bmj.com/cgi/reprint/70/6/784.pdf"></self-uri><self-uri xlink:role="abstract" xlink:type="simple" xlink:href="http://jnnp.bmj.com/cgi/content/abstract/70/6/784"></self-uri><self-uri xlink:role="fulltext" xlink:type="simple" xlink:href="http://jnnp.bmj.com/cgi/content/full/70/6/784"></self-uri><abstract><p>Plasma neurotensin (NT) was measured by radioimmunoassay in
propanol extracted and unextracted plasma from 16 parkinsonian patients
(four before treatment) and 16 age and sex matched controls. Mean
plasma NT concentrations were consistently higher in parkinsonian patients than in controls and higher in the four untreated patients than in levodopa treated patients suggesting that plasma NT measurement may represent an easy detectable additional index in diagnosing parkinsonism and provides a novel approach to research in this field.
</p></abstract></article-meta></front></pmc></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000331 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 000331 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonFranceV1
|flux= Pmc
|étape= Corpus
|type= RBID
|clé=
|texte=
}}
| This area was generated with Dilib version V0.6.29. |  |